1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Blood-Brain Barrier Market
2.2. Global Blood-Brain Barrier Market, By Disease, 2024 (US$ Million)
2.3. Global Blood-Brain Barrier Market, By Technology, 2024 (US$ Million)
2.4. Global Blood-Brain Barrier Market, By Geography, 2024 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2024

3. Blood-Brain Barrier Market: Competitive Analysis
3.1. Market Positioning of Key Blood-Brain Barrier Market Vendors
3.2. Strategies Adopted by Blood-Brain Barrier Market Vendors
3.3. Key Industry Strategies

4. Blood-Brain Barrier Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Blood-Brain Barrier Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Alzheimer’s Disease
5.3.2. Epilepsy
5.3.3. Parkinson’s Disease
5.3.4. Multiple Sclerosis
5.3.5. Hunter’s Syndrome
5.3.6. Brain Cancer

6. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Bispecific Antibody RMT Approach
6.3.1.1. Ossianix Blood-Brain Barrier Technology (Ossianix)
6.3.1.2. Brain Shuttle Technology (Roche)
6.3.1.3. Other Bispecific Antibodies Based Technologies
6.3.2. Trojan Horse Approach
6.3.2.1. Transcend Technology (biOasis)
6.3.2.2. LRP Technology (Angiochem)
6.3.2.3. IPRO Technology (Iproteos)
6.3.2.4. ArmaGen Technology Platform (ArmaGen)
6.3.2.5. Vect-Horus Technology Platform (Vect-Horus)
6.3.2.6. G-Technology (BBB Therapeutics)
6.3.2.7. Nano BBB Technology Platform (Sagetis Biotech)
6.3.2.8. Other Technologies Based on Trojan Horse Approach
6.3.3. Increasing the Permeability of BBB
6.3.3.1. SonoCloud Technology (CarThera)
6.3.3.2. SPG Technology (BrainsGate)
6.3.3.3. Other Technologies Based on Increasing Permeability of BBB
6.3.4. Passive Diffusion
6.3.4.1. SciFluor Life Sciences
6.3.5. Other Non-Invasive BBB Technologies
6.3.5.1. SMART Molecule Technology (ICBI)
6.3.5.2. Molecular Envelope Technology (Nanomerics)
6.3.5.3. Other Approaches (JCR Pharma, Cyclenium, Cerecor, Lauren Sciences, Protheragen)


7. North America Blood-Brain Barrier Market, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
7.3. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
7.4.Blood-Brain Barrier Market: By Region, 2023-2033, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
7.4.1.1.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
7.4.1.2.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
7.4.1.3.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)

8. UK and European Union Blood-Brain Barrier Market, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
8.3. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
8.4.Blood-Brain Barrier Market: By Region, 2023-2033, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
8.4.1.1.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
8.4.1.2.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
8.4.1.3.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
8.4.1.4.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
8.4.1.5. France
8.4.1.5.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
8.4.1.5.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
8.4.1.6.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)

9. Asia Pacific Blood-Brain Barrier Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
9.3. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
9.4.Blood-Brain Barrier Market: By Region, 2023-2033, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
9.4.1.1.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
9.4.1.2.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
9.4.1.3. India
9.4.1.3.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
9.4.1.3.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
9.4.1.4.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
9.4.1.5.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
9.4.1.6.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)

10. Latin America Blood-Brain Barrier Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
10.3. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
10.4.Blood-Brain Barrier Market: By Region, 2023-2033, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
10.4.1.1.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
10.4.1.2.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
10.4.1.3.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)

11. Middle East and Africa Blood-Brain Barrier Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
11.3. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
11.4.Blood-Brain Barrier Market: By Region, 2023-2033, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
11.4.1.1.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
11.4.1.2.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Blood-Brain Barrier Market: By Disease, 2023-2033, USD (Million)
11.4.1.3.2. Blood-Brain Barrier Market: By Technology, 2023-2033, USD (Million)

12. Company Profile
12.1. Allon Therapeutics, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Angiochem Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Armagen Technologies, Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. BrainsGate
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Bristol-Myers Squibb
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. BiOasis Technologies, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Cephalon Inc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Cerecor
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. CarThera
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Cytos Biotechnology AG
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Envivo Pharmaceuticals, Inc.
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Eli Lilly And Company
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. Sanofi Genzyme
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives
12.14. Iproteos S.L.
12.14.1. Company Overview
12.14.2. Financial Performance
12.14.3. Product Portfolio
12.14.4. Strategic Initiatives
12.15. Janssen Pharmaceutica NV
12.15.1. Company Overview
12.15.2. Financial Performance
12.15.3. Product Portfolio
12.15.4. Strategic Initiatives
12.16. Nanomerics
12.16.1. Company Overview
12.16.2. Financial Performance
12.16.3. Product Portfolio
12.16.4. Strategic Initiatives
12.17. Ossianix, Inc.
12.17.1. Company Overview
12.17.2. Financial Performance
12.17.3. Product Portfolio
12.17.4. Strategic Initiatives
12.18. Protheragen, Inc.
12.18.1. Company Overview
12.18.2. Financial Performance
12.18.3. Product Portfolio
12.18.4. Strategic Initiatives
12.19. F. Hoffman La-Roche
12.19.1. Company Overview
12.19.2. Financial Performance
12.19.3. Product Portfolio
12.19.4. Strategic Initiatives
12.20. Shire plc
12.20.1. Company Overview
12.20.2. Financial Performance
12.20.3. Product Portfolio
12.20.4. Strategic Initiatives